(MPC) Marathon Petroleum - Overview
Sector: EnergyIndustry: Oil & Gas Refining & Marketing | Exchange NYSE (USA) | Currency USD | Market Cap: 68.536m | Total Return 69.3% in 12m
Stock: Fuels, Petrochemicals, Asphalt, Natural Gas, Renewable Diesel
| Risk 5d forecast | |
|---|---|
| Volatility | 36.7% |
| Relative Tail Risk | -5.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.56 |
| Alpha | 58.48 |
| Character TTM | |
|---|---|
| Beta | 0.809 |
| Beta Downside | 1.060 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.75% |
| CAGR/Max DD | 0.58 |
EPS (Earnings per Share)
Revenue
Description: MPC Marathon Petroleum March 04, 2026
Marathon Petroleum Corporation (MPC) is a US-based integrated downstream energy company. It operates in refining, marketing, midstream, and renewable diesel sectors.
The Refining & Marketing segment processes crude oil and other feedstocks into various refined products, including transportation fuels and petrochemicals. This segment is central to the oil and gas refining and marketing sub-industry, which focuses on converting crude oil into usable products.
The Midstream segment manages the logistics of crude oil, refined products, and natural gas. This includes gathering, transporting, storing, and distributing these commodities, a critical function for connecting production with consumption.
The Renewable Diesel segment converts renewable feedstocks into renewable diesel. This segment addresses the growing demand for lower-carbon fuels within the energy sector.
For a deeper dive into MPCs financial performance and market position, consider exploring further research on ValueRay.
Headlines to watch out for
- Refining margins dictate profitability
- Crude oil prices impact feedstock costs
- Midstream segment provides stable cash flow
- Renewable diesel production expands revenue streams
- Regulatory changes affect environmental compliance costs
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 4.05b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -2.20 > 1.0 |
| NWC/Revenue: 3.84% < 20% (prev 2.61%; Δ 1.23% < -1%) |
| CFO/TA 0.10 > 3% & CFO 8.25b > Net Income 4.05b |
| Net Debt (30.69b) to EBITDA (11.63b): 2.64 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (299.0m) vs 12m ago -6.85% < -2% |
| Gross Margin: 7.73% > 18% (prev 0.07%; Δ 766.0% > 0.5%) |
| Asset Turnover: 161.7% > 50% (prev 176.1%; Δ -14.35% > 0%) |
| Interest Coverage Ratio: 5.95 > 6 (EBITDA TTM 11.63b / Interest Expense TTM 1.41b) |
Altman Z'' 3.27
| A: 0.06 (Total Current Assets 24.78b - Total Current Liabilities 19.68b) / Total Assets 85.56b |
| B: 0.46 (Retained Earnings 39.75b / Total Assets 85.56b) |
| C: 0.10 (EBIT TTM 8.38b / Avg Total Assets 82.21b) |
| D: 0.65 (Book Value of Equity 39.66b / Total Liabilities 61.47b) |
| Altman-Z'' Score: 3.27 = A |
Beneish M -3.19
| DSRI: 0.97 (Receivables 10.32b/11.14b, Revenue 132.97b/138.86b) |
| GMI: 0.87 (GM 7.73% / 6.69%) |
| AQI: 1.12 (AQ_t 0.26 / AQ_t-1 0.23) |
| SGI: 0.96 (Revenue 132.97b / 138.86b) |
| TATA: -0.05 (NI 4.05b - CFO 8.25b) / TA 85.56b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of MPC shares?
Over the past week, the price has changed by +5.31%, over one month by +23.49%, over three months by +52.46% and over the past year by +69.31%.
Is MPC a buy, sell or hold?
- StrongBuy: 7
- Buy: 5
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MPC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 208.3 | -16.1% |
| Analysts Target Price | 208.3 | -16.1% |
MPC Fundamental Data Overview March 23, 2026
P/E Forward = 12.5471
P/S = 0.5146
P/B = 3.9551
P/EG = 1.1299
Revenue TTM = 132.97b USD
EBIT TTM = 8.38b USD
EBITDA TTM = 11.63b USD
Long Term Debt = 30.50b USD (from longTermDebt, last quarter)
Short Term Debt = 2.86b USD (from shortTermDebt, last quarter)
Debt = 34.36b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 30.69b USD (from netDebt column, last quarter)
Enterprise Value = 99.22b USD (68.54b + Debt 34.36b - CCE 3.67b)
Interest Coverage Ratio = 5.95 (Ebit TTM 8.38b / Interest Expense TTM 1.41b)
EV/FCF = 20.81x (Enterprise Value 99.22b / FCF TTM 4.77b)
FCF Yield = 4.80% (FCF TTM 4.77b / Enterprise Value 99.22b)
FCF Margin = 3.58% (FCF TTM 4.77b / Revenue TTM 132.97b)
Net Margin = 3.04% (Net Income TTM 4.05b / Revenue TTM 132.97b)
Gross Margin = 7.73% ((Revenue TTM 132.97b - Cost of Revenue TTM 122.70b) / Revenue TTM)
Gross Margin QoQ = 9.61% (prev 7.95%)
Tobins Q-Ratio = 1.16 (Enterprise Value 99.22b / Total Assets 85.56b)
Interest Expense / Debt = 1.10% (Interest Expense 378.0m / Debt 34.36b)
Taxrate = 15.82% (372.0m / 2.35b)
NOPAT = 7.05b (EBIT 8.38b * (1 - 15.82%))
Current Ratio = 1.26 (Total Current Assets 24.78b / Total Current Liabilities 19.68b)
Debt / Equity = 1.98 (Debt 34.36b / totalStockholderEquity, last quarter 17.31b)
Debt / EBITDA = 2.64 (Net Debt 30.69b / EBITDA 11.63b)
Debt / FCF = 6.44 (Net Debt 30.69b / FCF TTM 4.77b)
Total Stockholder Equity = 16.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.92% (Net Income 4.05b / Total Assets 85.56b)
RoE = 24.01% (Net Income TTM 4.05b / Total Stockholder Equity 16.86b)
RoCE = 17.68% (EBIT 8.38b / Capital Employed (Equity 16.86b + L.T.Debt 30.50b))
RoIC = 14.63% (NOPAT 7.05b / Invested Capital 48.18b)
WACC = 6.19% (E(68.54b)/V(102.89b) * Re(8.83%) + D(34.36b)/V(102.89b) * Rd(1.10%) * (1-Tc(0.16)))
Discount Rate = 8.83% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.94%
[DCF] Terminal Value 82.53% ; FCFF base≈5.31b ; Y1≈4.15b ; Y5≈2.69b
[DCF] Fair Price = 160.6 (EV 77.98b - Net Debt 30.69b = Equity 47.29b / Shares 294.5m; r=6.19% [WACC]; 5y FCF grow -26.03% → 3.0% )
EPS Correlation: -44.84 | EPS CAGR: 31.68% | SUE: 2.23 | # QB: 1
Revenue Correlation: -71.73 | Revenue CAGR: -3.85% | SUE: 0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=5.96 | Chg7d=+0.246 | Chg30d=+1.050 | Revisions Net=+3 | Analysts=16
EPS current Year (2026-12-31): EPS=16.02 | Chg7d=+0.564 | Chg30d=+2.808 | Revisions Net=+3 | Growth EPS=+49.7% | Growth Revenue=-7.9%
EPS next Year (2027-12-31): EPS=14.98 | Chg7d=+0.061 | Chg30d=+1.187 | Revisions Net=+2 | Growth EPS=-6.5% | Growth Revenue=+2.9%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.1% (Discount Rate 8.8% - Earnings Yield 5.7%)
[Growth] Growth Spread = -6.7% (Analyst -3.5% - Implied 3.1%)